Lv4
408 积分 2025-09-23 加入
Molecular Subtypes and Genomic Profile of Primary Central Nervous System Lymphoma
1个月前
已完结
Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial
3个月前
已完结
The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation
4个月前
已完结
Ovarian high-grade serous carcinoma cells with low SMARCA4 expression and high SMARCA2 expression contribute to platinum resistance
4个月前
已完结
Gilteritinib or Chemotherapy for Relapsed or Refractory FLT3 -Mutated AML
4个月前
已完结
Targeting the 3D genome by anthracyclines for chemotherapeutic effects
4个月前
已完结
Anthelmintic resistance of intestinal nematodes to ivermectin and pyrantel in Estonian horses
4个月前
已完结
Gilteritinib or Chemotherapy for Relapsed or Refractory FLT3-Mutated AML
4个月前
已完结
FLT3ITD drives context-specific changes in cell identity and variable interferon dependence during AML initiation
4个月前
已完结
Efficacy and Safety of Axicabtagene Ciloleucel (Axi-cel) for the Treatment of Relapse/Refractory Non-Hodgkin's Lymphoma: Real-World Data in Chinese Population
5个月前
已关闭
皖公网安备34019202002308
